Compare GRMN & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRMN | EW |
|---|---|---|
| Founded | 1990 | 1958 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5B | 45.5B |
| IPO Year | 2000 | 2000 |
| Metric | GRMN | EW |
|---|---|---|
| Price | $203.52 | $86.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 21 |
| Target Price | ★ $239.50 | $94.68 |
| AVG Volume (30 Days) | 1.1M | ★ 3.5M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | ★ 3.11 | N/A |
| EPS | ★ 8.11 | 2.33 |
| Revenue | ★ $6,943,125,000.00 | $5,883,800,000.00 |
| Revenue This Year | $15.64 | $14.26 |
| Revenue Next Year | $6.70 | $9.77 |
| P/E Ratio | ★ $25.11 | $37.70 |
| Revenue Growth | ★ 16.56 | 10.60 |
| 52 Week Low | $169.26 | $65.94 |
| 52 Week High | $261.69 | $87.89 |
| Indicator | GRMN | EW |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 59.20 |
| Support Level | $193.27 | $83.60 |
| Resistance Level | $205.47 | $87.40 |
| Average True Range (ATR) | 3.93 | 1.76 |
| MACD | 2.96 | -0.28 |
| Stochastic Oscillator | 87.58 | 63.57 |
Garmin produces GPS-enabled hardware and software for five sectors: fitness, outdoors, automotive, aviation, and marine. Garmin has built a strong reputation for durable, high-precision devices through a vertically integrated design and manufacturing approach. The company's product lines include smartwatches, fitness trackers, communication equipment, and a comprehensive suite of systems for marine and aviation navigation. Garmin operates globally, with its business focused primarily on North America and Europe.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.